Plan B Takes Dr. Reddy’s Into Hot US Nexium Market
This article was originally published in PharmAsia News
Executive Summary
Shares of Dr. Reddy's surged on Indian bourses after the firm announced the launch of generic Nexium (esomeprazole magnesium) delayed release capsules in the US, after implementing a super-fast site transfer for the much anticipated product.